Todos Med Ltd (TOMDF)

[redspeed]

Update on Horsey Lympro

Looks like the analysis is all done. Likely done in Q4 as planned.

If the data wasn't good, probably zero issues with policies

I guess the policies are all the CEO's fault, eh?

Another CEO could have changed those polices, right?

Yes. It’s in the bag at this point in Germany, but policies slowing release

— Gerald Commissiong (@G_Commish) January 7, 2023